Botulinum toxin in temporomandibular disorder
DOI:
https://doi.org/10.33448/rsd-v12i14.44552Keywords:
Face; Botulinum toxins, type A; Temporomandibular joint dysfunction syndrome.Abstract
Daily challenges can trigger disturbances in the environmental, psychological, biological and cognitive domains, impacting systemic homeostasis and contributing to the emergence of disorders such as depression and anxiety. Patients exposed to such challenges have a higher incidence of disorders related to the temporomandibular joint (TMJ). The prevalence of temporomandibular disorder (TMD) has become recognized, with more than 100 million cases in the 1990s, resulting in the annual production of 3 million occlusal splints in the USA. Alternative approaches have been developed, offering comparable recovery rates. Symptoms associated with TMD include headache, ear pain, toothache, facial pain and tinnitus, often linked to psychological stress. Therapeutic success in TMJ is linked to a comprehensive plan, involving clinical and surgical approaches. Botulinum toxin (TxB) has seven forms, inhibiting the release of acetylcholine and inducing temporary muscle inactivity. Types A (TxB-A) and B (TxB-B) are applied clinically in specific areas. TxBo, type A, is effective in controlling muscle hyperactivity, especially when the origin of pain in TMD is myogenic. This review seeks to explore these interactions to provide a comprehensive overview of the therapeutic management of TMDs.
References
Abboud, W., et al. (2018). Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections. International Journal of Oral and Maxillofacial Surgery, 46(11), 1417–1423.
Aoki, K. R. (2005). Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology, 26(5), 785-793.
Azam, A., Manchanda, S., Thotapalli, S., & Kotha, S. B. (2015). BOTOX Therapy in Dentistry: A Review. Journal of International Oral Health, 7(2), 103-105.
Bastos, J. M., et al. (2017). Disfunção Temporomandibular: Uma Revisão De Literatura Sobre Epidemiologia, Sinais e Sintomas e Exame Clínico. Revista da Saúde e Biotecnologia, 1(1), 66-77.
Bonjardim, L. R., et al. (2005). Anxiety and depression in adolescents and their relationship with signs and symptoms of temporomandibular disorders. International Journal of Prosthodontics, 18(4), 347–352.
Calis, A. S., Colakoglu, Z., & Gunbay, S. (2019). The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders. Journal of Stomatology, Oral and Maxillofacial Surgery.
Calixtre, L., et al. (2014). Is there an association between anxiety/depression and temporomandibular disorders in college students? J Appl Oral Sci., 22(1), 15-21.
Carrara, S. V., et al. (2010). Termo do 1º Consenso em Disfunção Temporomandibular e Dor Orofacial. Dental Press J Orthod, 15(3), 114-120.
Couto, A. P. G. R., et al. (2022). Uso da toxina botulínica tipo A como alternativa terapêutica na disfunção temporomandibular: uma revisão de literatura, 15(8), 1-11.
Dias, R., & Fonseca, J. (2016). Disfunções Temporomandibulares (DTM): Introdução e Classificação. In: Almeida, A. M., Fonseca, J., & Félix, S. Dor orofacial e disfunções temporomandibulares: Tratamento farmacológico. 1º Ed., p. 17-26.
Ferreira, C., & Silva, M. (2016). Sinais e sintomas de desordem temporomandibular em mulheres e homens. CoDAS, 28(1), 17-21.
Gauer, M. D., et al. (2015). Diagnosis and Treatment of Temporomandibular Disorders. Am Fam Physician, 91(6), 378-386.
Grossmann, E., Grosmann, T. K. (2011). Cirurgia da articulação temporomandibular. Rev Dor, 12(2), 152-9.
Hosgor, H., & Altindis, S. (2020). Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 46(5), 335–340.
Kokkolla, O. (2018). Efficacy of stabilisation splint treatment on the oral health-related quality of life-A randomised controlled one-year follow-up trial. J Oral Rehabil, 45(5), 355-362.
Kucukguven, A., et al. (2021). A Novel Injection Technique to the Lateral Pterygoid Muscle for Temporomandibular Disorders: A Cadaveric Study. Plastic and Reconstructive Surgery, 148(5), 785e–790e.
Marciano, A., et al. (2014). Toxina Botulínica e sua aplicação na Odontologia. Revista de Iniciação Científica da Universidade Vale do Rio Verde, 1(4), 65-75.
Miloro, M., et al. (2016). Princípios de cirurgia bucomaxilofacial de Peterson. 3 ed. São Paulo: Santos.
Olender, D., et al. (2018). Botulinum toxin application in the treatment of anterior disc displacement in TMJ – review of literature. Prosthodontics, 68(2), 223-231.
Patel, A. A., et al. (2019). A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. British Dental Journal, 226(9), 667–672.
Paulino, M., et al. (2018). Prevalência de sinais e sintomas de disfunção temporomandibular em estudantes pré-vestibulandos: associação de fatores emocionais, hábitos parafuncionais e impacto na qualidade de vida. Ciência & Saúde Coletiva, 23(1), 173-186.
Pierce, C. J., et al. (1995). Dental splint prescription patterns: a survey. J Am Dent Assoc, 126(2), 248-54.
Popoff, M. R., Marvaud, J. C., & Raffestin, S. (2001). Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins. Annales Pharmaceutiques Françaises, 59(3), 176-190.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).
Sposito, M. M. M. (2009). Toxina Botulínica do Tipo A: mecanismo de ação. Acta Fisiatrica, 16(1), 25-37.
Thambar, S., et al. (2020). Botulinum toxin in the management of temporomandibular disorders: a systematic review. The British Journal of Oral & Maxillofacial Surgery, 58(5), 508–519.
Ting, P., & Freiman, A. (2004). “The story of Clostridium botulinum: from food poisoning to BOTOX”-review. Clinical Medicine: Journal of the Royal College of Physicians of London, 4(3), 258–261.
Velázquez, M. F., et al. (2015). Desarrollo de miastenia gravis tras administración de toxina botulínica en el síndrome de dolor miofascial. Rev Soc Esp Dolor, 22(3), 102-105.
Zavaneli, A. C., et al. (2013). Abordagem, diagnóstico e tratamento das disfunções temporomandibulares – relato de caso. Arch Health Invest, 7(12), 523-529.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Graziela Gonçalves; Roberto Teruo Suguihara; Daniella Pilon Muknicka
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
